by Mirjam Münch
Sleep-Wake Research Centre, Massey University, New Zealand
Mirjam Münch PhD, studies circadian rhythms and sleep. She is interested how (day-)light affects human physiology and behaviour in different age groups and has also worked together with architects and building scientists.
Light therapy was first developed to treat winter depression. Its rapid success led to using light in other areas of psychiatry, in particular for patients with dementia. A major development was the long-term randomized double blind placebo-controlled study (led by Eus van Someren in the Netherlands) of patients in a nursing home who showed a slower decline in cognition and functional limitations (activities of daily living) when bright lights were installed in their day-room, compared with patients exposed to normal illumination.
Spurred on by these important results, we have conducted two newer studies in Swiss nursing homes, with different kinds of light installations, that illustrate how light as an “architectural treatment” is becoming so popular. The first study in severely demented patients also used day-room polychromatic white lighting scenarios. These consisted of a dynamic ceiling lighting system in 9 day-rooms programmed to provide warm-white, lower intensity light in the morning and evening, and cool-white higher intensity light during the day. Twelve other day-rooms had conventional constant lighting. The systems were set in operation several months before the study began. After 8 weeks of data collection during the dark half of the year, we found no differences between the 41 patients receiving dynamic lighting and the 48 patients with conventional lighting, based on measures of emotional state, agitated behavior, quality of life, melatonin secretion, and circadian rest-activity cycles.
Given that there were windows in the day-rooms, and mobile patients were free to go outdoors into natural light at any time, we reconfigured the data analysis. Based on more than 800 hours of observation by trained assistants, we found that patients with higher average individual daily light exposure (>417 lx) showed significantly longer expression of emotional pleasure, and were more alert per daily observation than patients with lower daily light exposure. As assessed by caregivers, patients with higher individual light exposure also had a higher quality of life. Based on physiological rest-activity recordings over 8 weeks, patients with higher daily light exposure spent less time in bed and went to bed later. with later sleep onset. We concluded that higher daily light exposure (including daylight) can improve the emotional state and quality of life in severely demented patients.
Our second study used a different approach to illumination. Instead of bright light, an LED dawn-dusk simulation (DDS) lamp was placed at the head of the bed, for 20 dementia patients. The system was programmed for a slow naturalistic rise in light intensity in the morning and a similar, slow decline at night before sleep onset. After one baseline week, patients were randomized to receive DDS either for the first or second eight weeks of the study. Mood and cheerfulness upon awakening was significantly higher with the DDS, as was circadian stability (regularity of sleep-wake cycles) and ratings of quality of life. In addition to DDS illumination, dim, amber-colored bedroom lighting was used at night to provide visibility for nurses’ monitoring, as well as in the bathrooms, to minimize sleep disturbances. This provided sufficient light for safe visibility without stimulating the circadian system with a wake-up signal.
These are only two examples of positive effects following increased, or naturalistic ambient light exposure in patients with dementia. This theme is being adopted by an increasing number of architects and lighting designers for improving illumination in nursing homes. A goal is to develop more tailored systems matched to the needs of patient cohorts, and adjustable according to available daylight, season of the year, and geographic latitude.